INTRODUCTION
The Wnt family of proteins plays essential roles conserved from flies to human in many developmental processes including cell fate specification, polarity, migration and proliferation. It has becoming increasingly clear that Wnt proteins activate multiple intracellular signaling cascades to achieve the diverse biological functions. One such cascade that has been most intensely studied to date involves the multi-functional protein β-catenin; this cascade is commonly known as the canonical Wnt pathway. In this pathway, extracellular Wnt proteins (19 members in mammals) engage both the lowdensity lipoprotein receptor-related proteins (LRP-5 and LRP-6) [18, 22, 27, 31] and the Frizzled family of membrane receptors (11 members in mammals), resulting in stabilization of the cytosolic β-catenin through inhibition of GSK3β [13, 32] . The stabilized β-catenin accumulates and transports into the nucleus where it interacts with transcription factors including lymphoid enhancerbinding factor-1 (Lef-1) and T cell factors (Tcf1-4), leading to transcriptional activation of downstream target genes [7] .
For nearly a decade, bone biologists have studied Wnt signaling intensely. This strong interest was kindled by the discovery that loss-of-function mutations in the Wnt co-receptor LRP-5 causes the hereditary human disease osteoporosis-pseudoglioma syndrome [8] . Further supporting the role of LRP5 in bone mass regulation, multiple gain-of-function mutations in LRP5 were found to cause a high-bone-mass syndrome in humans [3, 16] . Moreover, loss-offunction mutations in a secreted Wnt antagonist sclerostin (SOST) were discovered to cause rare high-bone-mass syndromes known as sclerosteosis and the van Buchem disease [1, 2, 4, 25] . The role of Wnt signaling in bone formation, as revealed by the human genetic studies, was further demonstrated in mouse genetic models. Specifically, mice deficient in Lrp-5 (Lrp-5 -/-) exhibit low bone mass postnatally due to reduced osteoblast proliferation and function [14] . Moreover, mouse embryos lacking β-catenin in the skeletal progenitors failed to form osteoblasts altogether [6, 11, 12, 23] . Overall, genetic evidence from both human and mouse strongly support the notion that Wnt signaling positively regulates bone formation.
NONCANONICAL WNT SIGNALING AND OSTEOBLAST DIFFERENTIATION
In addition to the β-catenin-mediated pathway, Wnt signaling through β-catenin-independent mechanisms, collectively termed noncanonical pathways, also plays fundamental roles in the vertebrate embryo [29] . Most notably, a β-catenin-independent pathway that involves the Rac1 and Cdc42 small GTPases, as well as the downstream kinase JNK, has been implicated in the directed migration and intercalation of cells towards the midline during gastrulation, a process known as the convergent extension (CE) movement [5, 9, 10, 20] . This pathway is often considered to be similar to the planar cell polarity (PCP) pathway extensively studied in Drosophila. In addition, studies in Xenopus embryos have shown that
Wnt proteins can activate heterotrimeric G-proteins and lead to calcium mobilization within the cell [15] . This process, often known as the "Ca ++ pathway", is sensitive to pertussis toxin and therefore most likely mediated through the Gi subfamily of α subunits. Although the vast majority of studies on non-canonical Wnt signaling have been on its role on cell polarity and directed movement, recent evidence has revealed that β-catenin-independent mechanisms also play significant roles in osteoblast differentiation.
In an effort to uncover downstream effectors through which Wnt3a induces osteoblast differentiation, we serendipitously discovered a PKCδ-dependent pathway that contributes to Wnt-induced bone formation [28] (Fig. 1) . 
RAC1-JNK2 SIGNALING AS A CRITICAL COMPONENT OF CANONCIAL WNT SIGNALING
Although nuclear localization of β-catenin is a prerequisite for canonical Wnt signaling, the underlying mechanism is poorly un- Fig. 1 . A summary of two recent studies about non-canonical Wnt signaling in osteoblast differentiation. Tu et al. [28] demonstrated a PKCδ-mediated pathway that promotes the Runx2-Osterix (Osx) transition through a yet unknown mechanism. Takada et al. [26] showed that CaMKII-mediated activation of a histone methyltransferase (SETDB1-SET domain bifurcated 1) represses PPARγ transactivation of adipogenic target genes, thereby secondarily enhancing osteoblast differentiation. In both cases, the involvement of Frizzled family of receptors (Fz) has not been demonstrated (hence the question mark). In addition, Takada et al. did not provide evidence for the mechanism upstream of CaMKII. G: heterotrimeric G-proteins composed of α, β and γ subunits. P. T.: pertussis toxin. DAG: diacylglycerol. derstood. In a prevailing conventional view, β-catenin is stabilized in the cytoplasm to a threshold level that allows passive entry into the nucleus. A recent study from our group however challenges this view, and provides evidence that nuclear localization is a necessary regulatory step. In particular, Rac1 and JNK2 activation appears to be required for β-catenin nuclear localization and signaling [33] .
Perhaps the most surprising aspect of this finding is that the The role of Rac1 and JNK2 in β-catenin signaling has been confirmed by others in a colon adenoma model [21] . There, the authors found that loss of the tumor suppressor APC (adenomatous polyposis coli), which robustly stabilizes β-catenin, is insufficient for causing β-catenin nuclear localization, whereas addition activation of KRAS is effective. The authors further showed that KRAS activated Rac1 and JNK2, and inhibition of the latter two molecules abolished β-catenin nuclear localization and signaling in these cancer cells. Thus, the colon adenoma cancer cells appear to have hijacked the same mechanisms used by normal Wnt signaling.
RETHINKING CANONICAL VERSUS NONCANONICAL WNT PATHWAYS
Although "canonical" versus "noncanonical" Wnt pathways have been customarily used in the Wnt field, the new evidence calls for an understanding of these terms. First, it has become clear that the same Wnt ligand can activate multiple intracellular pathways in the same cell. This was evident in our studies where Wnt3a activates both the β-catenin and the PKCδ pathway [28] . The divergence in intracellular signaling pathways likely occurs at the level of cell-surface receptors, including both the Frizzled family members and the atypical receptor kinase Ryk [17, 24] , as well as the orphan receptor tyrosine kinase Ror2 [19] . Second, the same Wnt ligand can activate different pathways in different cells. For instance, we've shown that Wnt7b fails to activate β-catenin signaling in ST2 cells [28, 33] , but others have shown that it can activate the pathway in epithelial and vascular smooth muscle cells [30] . The difference could be caused by the presence of different receptors in different cells. Third, whereas β-catenin stabilization is clearly important, it is not synonymous with β-catenin signaling in the nucleus. Indeed, the additional regulatory steps for β-catenin signaling may well be "non-canonical", as demonstrated by the involvement of Rac1 and JNK2 [33] . Finally, whereas "canonical" is defined as β-catenin-dependent, the broad category of "non-canonical pathways" may include an unknown number of cascades that remain to be discovered. Thus, when it comes to Wnt signaling, one would be wise to keep a very open mind for the years to come.
